Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson's disease

被引：0
|
作者：
Dibilio, V.
Nicoletti, A.
Mostile, G.
Toscano, S.
Luca, A.
Raciti, L.
Vasta, R.
Cicero, C. E.
Contrafatto, D.
Zappia, M.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1537
引用
收藏
页码：S505 / S506
页数：2
相关论文
共 50 条
  • [41] The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease
    Oonk, Nicol G. M.
    Movig, Kris L. L.
    van der Palen, Job
    Nijmeijer, Henk-Willem
    van Kesteren, Mirjam E.
    Dorresteijn, Lucille D. A.
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (09) : 809 - 816
  • [42] Rhinorrhea: A Common Non-Dopaminergic Feature of Parkinson Disease
    Chou, Kelvin L.
    Koeppe, Robert A.
    Bohnen, Nicolaas I.
    [J]. NEUROLOGY, 2010, 74 (09) : A76 - A76
  • [43] Involvement of non-dopaminergic pathways in Parkinson's disease - Pathophysiology and therapeutic implications
    Bonnet, AM
    [J]. CNS DRUGS, 2000, 13 (05) : 351 - 364
  • [44] Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease
    Gunasingh J. Masilamoni
    Yoland Smith
    [J]. Journal of Neural Transmission, 2018, 125 : 337 - 363
  • [45] Belladonna plant and Parkinson's - A review of history of non-dopaminergic treatments of Parkinson's disease
    Rana, A. Q.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S163 - S163
  • [46] Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: A review
    Leroi, Iracema
    Collins, Deborah
    Marsh, Laura
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 104 - 114
  • [47] Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease
    Masilamoni, Gunasingh J.
    Smith, Yoland
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (03) : 337 - 363
  • [48] Xalithine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson's Disease
    Kasabova-Angelova, Alexandra
    Tzankova, Diana
    Mitkov, Javor
    Georgieva, Maya
    Tzankova, Virginia
    Zlatkov, Alexander
    Kondeva-Burdina, Magdalena
    [J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27 (12) : 2021 - 2036
  • [49] The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease
    Zampieri, Cris
    Salarian, Arash
    Carlson-Kuhta, Patricia
    Aminian, Kamiar
    Nutt, John G.
    Horak, Fay B.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (02): : 171 - 176
  • [50] The instrumented timed up and go test: Potential for assessing alteration in Parkinson's disease clinical subtypes
    Herman, T.
    Weiss, A.
    Giladi, N.
    Hausdorff, J. M.
    [J]. MOVEMENT DISORDERS, 2013, 28 : S117 - S117
12345